je.st
news
Provectus Remains Undervalued - CFO/COO Peter Culpepper Explains Why
2014-10-08 03:51:11| Logistics - Topix.net
In order to gain more insight on this investment opportunity, I conducted an email interview with Peter Culpepper, CFO and COO of Provectus. CFO/COO Culpepper elucidates important elements of Provectus' clinical studies, its relationship with Pfizer, and possible near-term value-driving catalysts that could benefit shareholders.
Tags: why
peter
remains
explains
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|